350616 <common-name>Methyl 2-[(4e)-4-[(4-butoxyphenyl)-hydroxymethylidene]-2,3-dioxo-5-(4-propan-2-ylphenyl)pyrrolidin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate</common-name> <description>Methyl 2-[(4e)-4-[(4-butoxyphenyl)-hydroxymethylidene]-2,3-dioxo-5-(4-propan-2-ylphenyl)pyrrolidin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate is a chemical compound with the formula C30H32N2O6S. With an average molecular weight of 548.70 g/mol, Methyl 2-[(4e)-4-[(4-butoxyphenyl)-hydroxymethylidene]-2,3-dioxo-5-(4-propan-2-ylphenyl)pyrrolidin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>5940248</pubchem-id> <chemical-formula>C30H32N2O6S</chemical-formula> <weight>548.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:47:35Z</created-at> <updated-at type="dateTime">2026-08-31T15:47:35Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCOC1=CC=C(C=C1)C(=C2C(N(C(=O)C2=O)C3=NC(=C(S3)C(=O)OC)C)C4=CC=C(C=C4)C(C)C)O</moldb-smiles> <moldb-formula>C30H32N2O6S</moldb-formula> <moldb-inchi>InChI=1S/C30H32N2O6S/c1-6-7-16-38-22-14-12-21(13-15-22)25(33)23-24(20-10-8-19(9-11-20)17(2)3)32(28(35)26(23)34)30-31-18(4)27(39-30)29(36)37-5/h8-15,17,24,33H,6-7,16H2,1-5H3/b25-23+</moldb-inchi> <moldb-inchikey>ALULIPZIPWVWOA-WJTDDFOZSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">548.1981079</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.8</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346509</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>Methyl 2-[(4e)-4-[(4-butoxyphenyl)-hydroxymethylidene]-2,3-dioxo-5-(4-propan-2-ylphenyl)pyrrolidin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Lipids and lipid-like molecules</superklass> <klass>Prenol lipids</klass> <subklass>Sesquiterpenoids</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300921</sync-id> <structure-inchikey>ALULIPZIPWVWOA-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40040000000000400000800802000000000040002010000000000000000000000000001002000020200000000000002004008000000000000000000000000000000000000000400000030200000000000020000010000100000200000000000000041020010020000040000000010000002000000100000000000000001000101020000040000000000000440000800080000000000000000000000020000101000000000000000000000400084000000008100000080000080000000000000000000040000000004000000020000000000000004000002000000200000000000018000000000005000040000000010420000000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAnAAAAKgAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIIACgAAAADAgZAKAAAAAMEBkBoAAAAAwMBBkBo AAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGACgAAAADBAYAKAAA AAMEBgBgAAAAAwEHACgAAAADAwYAKAAAAAMECAAoAAAAAwIGACgAAAADBAgA KAAAAAMCBkAoAAAAAwQHQCgAAAADAwZAKAAAAAMEBkAoAAAAAwQQQCgAAAAD AgYAKAAAAAMECAAoAAAAAwIIACgAAAADAgYAYAAAAAEDBgBgAAAAAQMGQCgA AAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAA AwMBBgBgAAAAAwEGAGAAAAABAwYAYAAAAAEDCABoAAAAAwEBCwABAAECAAID AAMEAAQFIAUGaAwGB2gMBwhoDAgJaAwJCmgMCAsgCwwoAgwNAA0OAA4PIA8Q KAIPESAREigCDhMgExRoDBQVaAwVFmgMFhdoDBYYIBgZKAIYGiAaGwAVHAAN HQAdHmgMHh9oDB8gaAwgIWgMISJoDCAjACMkACMlAAsmIAoFaAwRDCAXE2gM Ih1oDEIEAAAABgUKCQgHBgUPDg0MEQUUExcWFQYeHyAhIh0XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:37Z</structure-indexed-at> </compound>